Ridgeback Capital Investments
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Late Stage Venture, Growth, Buyout
Geographical Focus
United States
Industries Focus
- Healthcare
- Education
- Health Care
- Life Sciences
- Pharmaceuticals
- Biotechnology
- Pharmaceutical
- Life Science
- Therapeutics
- Biopharma
- Health Diagnostics
- Genetics
- Innovation Management
- Personal Health
- Association
Investor Details Founded: 2006
Ridgeback Capital Investments is a private equity firm specializing in healthcare investments, focusing on life-saving and life-changing therapies. The firm invests in both private and public companies dedicated to the development of transformative medicines and technologies. Founded in 2006 by Dr. Wayne Holman, Ridgeback Capital has a track record of supporting innovative companies in the biotechnology and pharmaceutical sectors.
The firm's investment strategy emphasizes patient capital, recognizing that healthcare advancements often require long-term commitment. Ridgeback Capital seeks to partner with companies that are creating life-saving and life-changing technologies, providing the necessary support to bring these innovations to market. The firm has been involved in various stages of investment, including seed, early-stage, late-stage venture, growth, and buyouts.
Ridgeback Capital's portfolio includes a diverse range of healthcare companies, from emerging biotechs to established players. The firm's strategic investments reflect its commitment to driving growth and innovation in the healthcare sector, aiming to make a significant impact on global health through its support of pioneering companies and therapies.
Requirements
- Focus on life-saving and life-changing therapies
- Commitment to long-term growth
- Innovative technologies in biotechnology and pharmaceuticals
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Senti Biosciences
- Turnstone Biologics
- 4D Molecular Therapeutics
- LENZ Therapeutics
- Intercept Pharmaceuticals
- Vertex Pharmaceuticals
- Chimeric Therapeutics
- Genfit
- Regeneron Pharmaceuticals
- United Therapeutics
- Sangamo Therapeutics
- Biomarin Pharmaceutical
- Adaptimmune Therapeutics
- Celgene Corporation
- Gilead Sciences
- Caribou Biosciences
- Senti Bio
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$14.95
-
$39.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Ridgeback Capital Investments?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim